CleanTech Lithium

Financials:

Primary ticker: London, OTC, Frankfurt and Berlin (AIM:CTL, OTC CTLHF.PKC)
Stage of development: Exploration
Primary minerals: Lithium
Project to promote: Laguna Verde, Francisco Basin, Llamara
Project location: Chile
Website: ctlithium.com
Corporate presentation: Click here
Corporate video: Click here

CleanTech Lithium (AIM:CTL, OTC CTLHF.PKC) is a carbon neutral lithium development company in Chile. Its mission is to produce battery grade, net-zero lithium and be the greenest lithium supplier to the EV market.

Based in the lithium triangle, the world’s centre for battery grade lithium, the Company holds licences over three substantial lithium projects (521km2) – Laguna Verde, Francisco Basin and Llamara. Total lithium resources exceed 2 million tonnes LCE. Laguna Verde has robust economics demonstrating a NPV8 of US$1.83bn and IRR of 45.1% for 30 years of production at 20,000tpa. CleanTech will utilise Direct Lithium Extraction, a proven technology and renewable power, to achieve sustainable commercial scale production in 2025.

Cash: GBP$10 M
Debt: NIL

Major shareholders:
Aldo Boitano – 9%
Jason Baverstock – 9.5%
Regal Emerging Fund – 16.5%
Luke Jarvis – 4%
Management Ownership – 20%

Management Profile

–
–

What is your rationale for taking part in 121 Mining Investment?

We are looking to promote the Company having just listed on OTC. As a public company we can not comment on any potential fundraisings.

What recent news would you like to highlight to investors attending?

We will provide a presentation at the event which will provide the update information which will come out over the next few months.

What are your key goals in 3 months, 6 months, 12 months?

3 Months:
Covered in a presentation.

6 Months:
Covered in a presentation.

12 Months:
Covered in a presentation.

What do you see as the key risks and challenges facing your company at the moment and how are you overcoming these?

See the presentation.

What do you think makes your company such a compelling investment?

See the presentation.

What are the top 3 key investor takeaways?

See the presentation.